A lawmaker from Britain’s opposition Labour party stirred a political row on Wednesday after describing U.S. drug makers Pfizer (NYSE:PFE) as “rapists” in comments criticising the government for its handling of a potential takeover of AstraZeneca. Pfizer Inc. (NYSE:PFE) net profit margin is 81.20% and weekly performance is 0.28%. On last trading day company shares ended up $29.10. Analysts mean target price for the company is $33.97. Pfizer Inc. (NYSE:PFE) distance from 50-day simple moving average (SMA50) is -5.92%.
Merck & Co. Inc. (NYSE:MRK) will sell its ophthalmology assets in Japan and other key markets in Europe and the Asia-Pacific to Japanese drugmaker Santen Pharmaceutical Co. Ltd. for $600 million upfront and additional payments based on sales milestones, the companies announced Tuesday. Merck & Co., Inc. (NYSE:MRK) shares advanced 1.11% in last trading session and ended the day on $56.37. MRK gross Margin is 61.30% and its return on assets is 5.70%.Merck & Co., Inc. (NYSE:MRK) quarterly performance is 3.30%.
Abbott Laboratories (NYSE:ABT) announced positive interim data from the RApid Diagnosis of Infections in the CriticAlly IlL (RADICAL) study. The RADICAL study analyzed samples from more than 180 critically ill patients with suspected severe infections and compared the results of Abbott’s technology (IRIDICA) to the current standard of care. Abbott Laboratories (NYSE:ABT) shares moved up 0.68% in last trading session and was closed at $39.93, while trading in range of $39.77 – $40.12. Abbott Laboratories (NYSE:ABT) year to date (YTD) performance is 5.38%.
GlaxoSmithKline Plc (ADR) (NYSE:GSK) executive Mark Reilly had little inkling he would be charged with leading a network of corruption in China’s pharmaceutical industry, two sources with ties to the businessman and knowledge of the investigation said. GlaxoSmithKline plc (ADR) (NYSE:GSK) ended the last trading day at $55.19. Company weekly volatility is calculated as 1.02% and price to cash ratio as 22.11.GlaxoSmithKline plc (ADR) (NYSE:GSK) showed a positive weekly performance of 0.69%.
AstraZeneca plc (ADR) (NYSE:AZN)’s stock had its “buy” rating restated by research analysts at Citigroup Inc. in a report released on Wednesday, Stock Ratings Network reports. AstraZeneca plc (ADR) (NYSE:AZN) net profit margin is 8.00% and weekly performance is -0.04%. On last trading day company shares ended up $78.29. Analysts mean target price for the company is $76.67. AstraZeneca plc (ADR) (NYSE:AZN) distance from 50-day simple moving average (SMA50) is 14.07%.